Tag: SNTL

BMSN, AMBS & Extended Watchlist

Yesterday in reference to BMSN, we stated that “we are expecting to see a pullback at some point. In such an event, we’d like to see the support hold off of the 50DMA of .001.”  Sure enough, that’s exactly what we saw, as the stock bounced off of .0011 before closing at .0018. Not only did BMSN follow our prediction to the letter, but it managed a 64% intraday gain off of the bounce as well.Accumulation remains at an all-time high, with close to three-quarters of a million dollars changing hands yesterday, a record-setting volume day for the stock. This leads us to believe that there is certainly something left in the tank for BMSN, and we will continue to monitor the Level 2 as we do with every ticker that’s high on our watchlist, to make sure that support holds in the .001’s.

___

Amarantus Bioscience, Inc. AMBS

AMBS had another great day on Wednesday, raking in some more serious gains. We observed a new high of .195, on heavy momentum, much like BMSN. Yesterday was the third highest volume day the stock has logged in the past two months, with $4.5M in dollar volume. When we see momentum in a high-flyer like this, it’s easy to get excited, yet we remain vigilant. It’s important not to let greed run the table, and protect those profits where you can, after all, we’ve already seen cumulative gains of 1047% from AMBS.

___

Extended Watchlist:

PNCH, SNTL, UNLA, PRTN, EGCT, BGMD, DUSS

BMSN, AMBS, AAPL & Extended Watchlist

BMSN has been like a rocket lately, blasting off since we first alerted the stock back on December 26th.We have seen five consecutive days of gains, with Monday’s action breaking a previous resistance point of .0021 and reaching a high of ,0024, before closing at .0016.Considering the momentum we witnessed over the past five sessions, we are expecting to see a pullback at some point. In such an event, we’d like to see the support hold off of the 50DMA of .001.

Our next key level of resistance is going to be at .0024. If it can get past that, the next level is .003, and .004 (200DMA).

___

 

Amarantus Bioscience, Inc. AMBS

We first began talking about AMBS on November 6th. Another one on a serious uptrend; in the past 14 days of trading, the stock has seen just two days of closing in the red.

AMBS will be co-hosting an international symposium , the #C4CT Concussion Awareness Conference, “with the purpose of bringing thought leaders in the field of Traumatic Brain Injury (“TBI”) drug and diagnostic research & development, professional athletes, former professional athletes and celebrity sports figureheads that share the Company’s, TCMG’s and Brewer’s desire to support research into new TBI treatments, sports leagues who have social and fiduciary responsibilities to improve player safety and caring for former players previously affected by TBI and cognitive disorders, as well as other key stakeholders in the ongoing social discussion regarding head injuries and their side effects.”

BARCHART.COM currently has AMBS rated a “100% Buy”

We had stated before that we were looking for a break past .13, and that it would bring us into bluesky breakout mode, and now that it has done so, we’re going to hold onto our hats, because there’s no telling where it could stop. We’d like to see .13 hold as the new base level of support.

___

Apple, Inc. AAPL

AAPL was as low as 510.24 on Dec. 21st, and dipping as low as 504.66 on December 27th. With all of the hype coming from “fiscal cliff” negotiations, Monday’s big rally (closed at 532.1729) has the stock trading close to 550.00 premarket today.

___
Extended Watchlist:

 MSSD, BTHR, FORC, PPHM, MDIN, CTIX, SNTL, DNYS, KWK, NOK

Blue Horseshoe Stocks 2012 Wrap-Up Report

The short week that is now upon us will mark the beginning of a new year! 2012 was an extremely successful stretch for us, and we are anxious to make 2013 even better. A tall order, but one that we will gladly attempt to fill, and we hope you will stay with us every step of the way! Before we jump into today’s report, lets have a look at our Top 5 Winning Picks from 2012.

  1. ATRN  Range: .0148-.3599  Gained: 2332%
  2. BBDA  Range: .0015-.0199  Gained: 1227%
  3. ANTS  Range: .0034-0328  Gained: 865%
  4. MWIP  Range: .0024-.0199  Gained: 729%
  5. AMBS  Range: .017-.1295  Gained: 662%

Let us also not forget our series of medical marijuana round-up reports that we began publishing on October 16th. The following weeks brought us cumulative gains on the order of 885% from stocks contained in those reports. We had success across the board this year, including swathes of other percentage gains, the total of which surely numbers in the tens-of-thousands.

Like we said, the wins will continue to pile up in 2013, and based on how things have been going, we anticipate this will be our best year ever. You most assuredly don’t want to miss it. The wildly successful “Extended Watchlist” portion of our daily reports that we implemented this year will continue to be a staple moving forward, and as always we are open to correspondence/suggestions from our reader-base.

___

Extended Watchlist:

 BMSN, IVAN, LXRX, HLNT, PPHM, DNYS, SNTL, LTSN